By Alex Ho
Investing.com – Fujifilm Holdings Corp. (T:) surged 5% on Tuesday morning in Asia after Japan said it is considering using an anti-influenza medication developed by a Fujifilm group company to treat coronavirus patients.
Katsunobu Kato, Japan’s health minister, said on Saturday that the country is planning to recommend using Avigan to treat the new coronavirus.
Avigan is an anti-influenza drug developed by a Fujifilm group company that has previously been used to treat Ebola, Fujifilm said on its website. Citing Kato, Bloomberg said test dosages have shown effects in mild and asymptomatic coronavirus cases.
The company’s shares in Japan jumped 4.9% to 5,680 yen by 11:25 PM ET (03:25 GMT). They jumped as much as 8.8% earlier in the day. That compared to the Nikkei 225, which slumped more than 3% today, on escalating concern over the global coronavirus outbreak.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.